What role does FT3 play in blood sugar?

FT3 (free triiodothyronine) is the active thyroid hormone and plays a significant role in blood sugar regulation. It enhances hepatic gluconeogenesis, increases glucose uptake in peripheral tissues, and modulates insulin sensitivity. Both hyperthyroidism (high FT3) and hypothyroidism (low FT3) can disrupt glucose homeostasis, leading to hyperglycemia or hypoglycemia, respectively. However, the evidence for FT3's role in blood sugar comes primarily from mechanistic and observational studies, not from large-scale human trials specifically targeting FT3 as a modifiable factor for glycemic control. In clinical practice, FT3 is measured as part of thyroid function tests, not as a routine marker for blood sugar management. Consumer DNA tests (e.g., MyBody-X) do not measure FT3 levels; they may analyze genetic variants in thyroid-related genes (e.g., DIO2, TSHR) with small effect sizes. The evidence for using FT3 or its genetic proxies to personalize blood sugar interventions is weak. Caveat: If you have concerns about blood sugar or thyroid function, standard blood tests (TSH, fT3, fT4, glucose, HbA1c) are essential and should be interpreted by a physician.